Comparison

Larotrectinib-d7 European Partner

Item no. HY-12866S-1ea
Manufacturer MedChem Express
Amount 1ea
Category
Type Molecules
Specific against other
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Available
Product Description
Larotrectinib-d7 (LOXO-101-d7) is the deuterium labeled Larotrectinib. Larotrectinib (LOXO-101) is an ATP-competitive oral, selective inhibitor of the tropomyosin-related kinase (TRK) family receptors, with low nanomolar 50% inhibitory concentrations against all three isoforms (TRKA, B, and C).
StorageTemperature
Please store the product under the recommended conditions in the Certificate of Analysis.
MolecularWeight
435.48
Clinical Information
No Development Reported
Research Area
Cancer
Pathway
Neuronal Signaling; Protein Tyrosine Kinase/RTK; Apoptosis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close